Table 1B. Relationships between clinicopathological features of ESCC and expression of AQP1.
| Other group (n=30) |
Cytoplasm dominant group (n=20) |
P value | |
|---|---|---|---|
| Sex | |||
| Male | 25 | 17 | 0.875 |
| Female | 5 | 3 | |
| Age | |||
| <65 | 16 | 14 | 0.235 |
| ≥65 | 14 | 6 | |
| Histology type | |||
| Well/Moderate | 22 | 13 | 0.530 |
| Poor | 8 | 7 | |
| Location | |||
| Ce-Ut | 3 | 2 | 0.621 |
| Mt | 16 | 8 | |
| Lt-Ae | 11 | 10 | |
| Tumor size (mm) | |||
| <50 | 19 | 12 | 0.812 |
| ≥50 | 11 | 8 | |
| Lymphatic invasion | |||
| Negative | 12 | 10 | 0.486 |
| Positive | 18 | 10 | |
| Venous invasion | |||
| Negative | 14 | 12 | 0.354 |
| Positive | 16 | 8 | |
| pT | |||
| pT1 | 13 | 6 | 0.338 |
| pT2-4 | 17 | 14 | |
| pN | |||
| pN0 | 15 | 4 | 0.028* |
| pN1-3 | 15 | 16 | |
| Post-operative therapy | |||
| None | 12 | 6 | 0.468 |
| Done | 18 | 14 | |
pT: pathological T stage, pN: pathological N stage
* p<0.05: Fisher's exact test.